You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新華醫療(600587.SH)擬掛牌轉讓高新區醫院80%股權
格隆匯 04-17 19:18

格隆匯4月17日丨新華醫療(600587.SH)公佈,公司擬通過產權交易中心公開掛牌方式出售全資子公司新華泰康投資控股(北京)有限公司(“新華泰康”)所持有的控股子公司南陽市骨科高新區醫院有限公司(“高新區醫院”)80%的股權。

高新區醫院成立於2014年4月21日,其註冊資本為人民幣1060萬元,其中新華醫療的全資子公司新華泰康認繳出資額為848萬元,佔其註冊資本的比例為80%;韓富強認繳出資額212萬元,佔其註冊資本的比例為20%;其經營範圍為:醫療、醫院運營服務、技術服務、技術諮詢;藥品、醫療器械I、II、III類、醫用耗材銷售;房屋租賃。

高新區醫院目前尚處於建設中,醫院建設完成並形成穩定收入和盈利前,仍需要投入較多的資金、人員和管理成本。為降低公司經營風險,更好地促進主業發展、優化產業佈局,公司結合“整合、升級、提效”的管理方針,綜合考慮投資成本等因素,同意全資子公司新華泰康掛牌轉讓高新區醫院80%的股權。

公司此次股權轉讓交易成交價格以最後摘牌價格為準,鑑於後續公司將履行國資管理單位評估結果備案核准和底價確認程序,公司尚無法確定轉讓標的資產的掛牌價格,此次交易對公司財務狀況及經營成果等影響以交易完成後的計算結果為準。公司將根據交易進展及時披露對公司業績影響情況。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account